326 related articles for article (PubMed ID: 20223661)
1. Novel pyrrolyl 2-aminopyridines as potent and selective human beta-secretase (BACE1) inhibitors.
Malamas MS; Barnes K; Hui Y; Johnson M; Lovering F; Condon J; Fobare W; Solvibile W; Turner J; Hu Y; Manas ES; Fan K; Olland A; Chopra R; Bard J; Pangalos MN; Reinhart P; Robichaud AJ
Bioorg Med Chem Lett; 2010 Apr; 20(7):2068-73. PubMed ID: 20223661
[TBL] [Abstract][Full Text] [Related]
2. Pyridinyl aminohydantoins as small molecule BACE1 inhibitors.
Zhou P; Li Y; Fan Y; Wang Z; Chopra R; Olland A; Hu Y; Magolda RL; Pangalos M; Reinhart PH; Turner MJ; Bard J; Malamas MS; Robichaud AJ
Bioorg Med Chem Lett; 2010 Apr; 20(7):2326-9. PubMed ID: 20202842
[TBL] [Abstract][Full Text] [Related]
3. Acylguanidines as small-molecule beta-secretase inhibitors.
Cole DC; Manas ES; Stock JR; Condon JS; Jennings LD; Aulabaugh A; Chopra R; Cowling R; Ellingboe JW; Fan KY; Harrison BL; Hu Y; Jacobsen S; Jin G; Lin L; Lovering FE; Malamas MS; Stahl ML; Strand J; Sukhdeo MN; Svenson K; Turner MJ; Wagner E; Wu J; Zhou P; Bard J
J Med Chem; 2006 Oct; 49(21):6158-61. PubMed ID: 17034121
[TBL] [Abstract][Full Text] [Related]
4. A therapeutic antibody targeting BACE1 inhibits amyloid-β production in vivo.
Atwal JK; Chen Y; Chiu C; Mortensen DL; Meilandt WJ; Liu Y; Heise CE; Hoyte K; Luk W; Lu Y; Peng K; Wu P; Rouge L; Zhang Y; Lazarus RA; Scearce-Levie K; Wang W; Wu Y; Tessier-Lavigne M; Watts RJ
Sci Transl Med; 2011 May; 3(84):84ra43. PubMed ID: 21613622
[TBL] [Abstract][Full Text] [Related]
5. Regulation of proBACE1 by glycosaminoglycans.
Small DH; Klaver DW; Beckman M
Neurodegener Dis; 2008; 5(3-4):206-8. PubMed ID: 18322391
[TBL] [Abstract][Full Text] [Related]
6. Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitors.
Wang YS; Strickland C; Voigt JH; Kennedy ME; Beyer BM; Senior MM; Smith EM; Nechuta TL; Madison VS; Czarniecki M; McKittrick BA; Stamford AW; Parker EM; Hunter JC; Greenlee WJ; Wyss DF
J Med Chem; 2010 Feb; 53(3):942-50. PubMed ID: 20043700
[TBL] [Abstract][Full Text] [Related]
7. Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions.
Klaver DW; Wilce MC; Cui H; Hung AC; Gasperini R; Foa L; Small DH
Biol Chem; 2010 Aug; 391(8):849-59. PubMed ID: 20731541
[TBL] [Abstract][Full Text] [Related]
8. Carbazole-containing arylcarboxamides as BACE1 inhibitors.
Bertini S; Asso V; Ghilardi E; Granchi C; Manera C; Minutolo F; Saccomanni G; Bortolato A; Mason J; Moro S; Macchia M
Bioorg Med Chem Lett; 2011 Nov; 21(22):6657-61. PubMed ID: 21986588
[TBL] [Abstract][Full Text] [Related]
9. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.
Sankaranarayanan S; Price EA; Wu G; Crouthamel MC; Shi XP; Tugusheva K; Tyler KX; Kahana J; Ellis J; Jin L; Steele T; Stachel S; Coburn C; Simon AJ
J Pharmacol Exp Ther; 2008 Mar; 324(3):957-69. PubMed ID: 18156464
[TBL] [Abstract][Full Text] [Related]
10. Piperazine sulfonamide BACE1 inhibitors: design, synthesis, and in vivo characterization.
Cumming J; Babu S; Huang Y; Carrol C; Chen X; Favreau L; Greenlee W; Guo T; Kennedy M; Kuvelkar R; Le T; Li G; McHugh N; Orth P; Ozgur L; Parker E; Saionz K; Stamford A; Strickland C; Tadesse D; Voigt J; Zhang L; Zhang Q
Bioorg Med Chem Lett; 2010 May; 20(9):2837-42. PubMed ID: 20347593
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of potent beta-secretase (BACE1) inhibitors with P1' carboxylic acid bioisosteres.
Kimura T; Hamada Y; Stochaj M; Ikari H; Nagamine A; Abdel-Rahman H; Igawa N; Hidaka K; Nguyen JT; Saito K; Hayashi Y; Kiso Y
Bioorg Med Chem Lett; 2006 May; 16(9):2380-6. PubMed ID: 16481167
[TBL] [Abstract][Full Text] [Related]
12. Aminoimidazoles as potent and selective human beta-secretase (BACE1) inhibitors.
Malamas MS; Erdei J; Gunawan I; Barnes K; Johnson M; Hui Y; Turner J; Hu Y; Wagner E; Fan K; Olland A; Bard J; Robichaud AJ
J Med Chem; 2009 Oct; 52(20):6314-23. PubMed ID: 19757823
[TBL] [Abstract][Full Text] [Related]
13. Prolonged stability by cyclization: Macrocyclic phosphino dipeptide isostere inhibitors of beta-secretase (BACE1).
Huber T; Manzenrieder F; Kuttruff CA; Dorner-Ciossek C; Kessler H
Bioorg Med Chem Lett; 2009 Aug; 19(15):4427-31. PubMed ID: 19523824
[TBL] [Abstract][Full Text] [Related]
14. New pyrazolyl and thienyl aminohydantoins as potent BACE1 inhibitors: exploring the S2' region.
Malamas MS; Erdei J; Gunawan I; Barnes K; Hui Y; Johnson M; Robichaud A; Zhou P; Yan Y; Solvibile W; Turner J; Fan KY; Chopra R; Bard J; Pangalos MN
Bioorg Med Chem Lett; 2011 Sep; 21(18):5164-70. PubMed ID: 21835615
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: structure-activity relationship of the aryl region.
Probst GD; Bowers S; Sealy JM; Stupi B; Dressen D; Jagodzinska BM; Aquino J; Gailunas A; Truong AP; Tso L; Xu YZ; Hom RK; John V; Tung JS; Pleiss MA; Tucker JA; Konradi AW; Sham HL; Jagodzinski J; Toth G; Brecht E; Yao N; Pan H; Lin M; Artis DR; Ruslim L; Bova MP; Sinha S; Yednock TA; Gauby S; Zmolek W; Quinn KP; Sauer JM
Bioorg Med Chem Lett; 2010 Oct; 20(20):6034-9. PubMed ID: 20822903
[TBL] [Abstract][Full Text] [Related]
16. Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretase.
Congreve M; Aharony D; Albert J; Callaghan O; Campbell J; Carr RA; Chessari G; Cowan S; Edwards PD; Frederickson M; McMenamin R; Murray CW; Patel S; Wallis N
J Med Chem; 2007 Mar; 50(6):1124-32. PubMed ID: 17315857
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of 5,5'-disubstituted aminohydantoins as potent and selective human beta-secretase (BACE1) inhibitors.
Malamas MS; Erdei J; Gunawan I; Turner J; Hu Y; Wagner E; Fan K; Chopra R; Olland A; Bard J; Jacobsen S; Magolda RL; Pangalos M; Robichaud AJ
J Med Chem; 2010 Feb; 53(3):1146-58. PubMed ID: 19968289
[TBL] [Abstract][Full Text] [Related]
18. Potent pyrrolidine- and piperidine-based BACE-1 inhibitors.
Iserloh U; Wu Y; Cumming JN; Pan J; Wang LY; Stamford AW; Kennedy ME; Kuvelkar R; Chen X; Parker EM; Strickland C; Voigt J
Bioorg Med Chem Lett; 2008 Jan; 18(1):414-7. PubMed ID: 18023580
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
[TBL] [Abstract][Full Text] [Related]
20. Boom in the development of non-peptidic beta-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease.
Silvestri R
Med Res Rev; 2009 Mar; 29(2):295-338. PubMed ID: 18651582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]